Back to results
US 2022/0024925 A1Published application
Deuterium-Substituted 7-Substituted-2-(Benzylamino)-6-Ozopurine Compounds and Uses Thereof
AssigneeAcurx Pharmaceuticals, LLC
InventorXiang Y. YU
Life of this patent
Estimating the term…
Abstract
The invention relates to compounds of formula (I): The compounds are useful as antibacterial agents, especially again Clostridium difficile-associated diseases.
Claims14
A compound represented by Formula I:
- or a pharmaceutically acceptable salt thereof, wherein:
- each of Y1, Y2, Y3a, Y3b, Y4, Y5, Y6, Y7, Y8a, Y8b, Y9a, Y9b, Y10a, Y10b, Y11a, Y11b, Y12a, Y12b, Y13a and Y13b is independently selected from hydrogen or deuterium;
- and
- at least one of Y1, Y2, Y3a, Y3b, Y4, Y5, Y6, Y7, Y8a, Y8b, Y9a, Y9b, Y10a, Y10b, Y11a, Y11b, Y12a, Y12b, Y13a and Y13b is deuterium;
- The invention excludes the compound with Y1, Y2, Y3a, Y3b, Y4, Y5, Y6, Y7, Y8a, Y8b, Y9a, Y9b as hydrogen and Y10a, Y10b, Y11a, Y11b, Y12a, Y12b, Y13a and Y13b as deuterium.
2 more elements
Dependencies are inferred from the claim text.